BECTON, DICKINSON AND COMPANY Proceeds from (Repayments of) Commercial Paper
BECTON, DICKINSON AND COMPANY (BDX) reported Proceeds from (Repayments of) Commercial Paper of $455.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfCommercialPaper · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY proceeds from (repayments of) commercial paper for fiscal 2025 was $455.00M, a 13.75% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY proceeds from (repayments of) commercial paper for fiscal 2024 was $400.00M.
- BECTON, DICKINSON AND COMPANY proceeds from (repayments of) commercial paper for fiscal 2023 was -$230.00M, a 200.00% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY proceeds from (repayments of) commercial paper for fiscal 2022 was $230.00M.
| Period end | Proceeds from (Repayments of) Commercial Paper 12 month |
|---|---|
| 2025-09-30 | $455.00M 10-K · filed 2025-11-25 |
| 2024-09-30 | $400.00M 10-K · filed 2025-11-25 |
| 2023-09-30 | -$230.00M 10-K · filed 2025-11-25 |
| 2022-09-30 | $230.00M 10-K · filed 2024-11-27 |
| 2021-09-30 | $0.00 10-K · filed 2023-11-21 |
| 2020-09-30 | $0.00 10-K · filed 2022-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |